Recruiting
Phase 1
Phase 2

Neratinib & Valproate

Sponsor:

Virginia Commonwealth University

Code:

NCT03919292

Conditions

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Neratinib

Divalproex Sodium

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-09. This information was provided to ClinicalTrials.gov by Virginia Commonwealth University on 2025-04-16.